VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bruce Olsten who wrote (3902)	12/19/1997 9:00:00 AM
From: Zebra 365	Read Replies (4) of 23519

Thanks for the link. Of course, the ones on whom MUSE works have better things to do than post on web newsgroups. <gg> Seriously, I feel sorry for those who think that Viagra will work where Caverject or MUSE failed, but again they will be trying a combination of Viagra and Caverject or Viagra and MUSE very quickly. This is also why I think the longer Viagra takes 'til approval, the worse off we are as investors in Vivus. So far, Viagra has no failures in the marketplace because it has no distribution. Therefore the effect on MUSE market is unknown and that uncertainty is killing our stock. (Insert hackneyed phrase, "The Street hates uncertainty", here) My rough impression of effectiveness (defined as intercourse) applied to all men with ED from any cause: Placebo or Yohimbine...............20% Viagra (no data, just a guess).....30% MUSE.......................................40% Caverject...................................60% Vacuum pump...........................80% A combination of any two of these (except MUSE and Caverject, same drug) will be more effective IMHO. Don't kid yourself, this is a tough problem and there is no panacea. Zebra

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next